Advertisement

Topics

Deal Watch: Takeda Continues Transaction Spree With Four More Deals

13:34 EDT 4 Aug 2017 | SCRIP

Takeda's recent deals include a license in Asian for Tesaro's PARP inhibitor Zejula. Meanwhile, Japanese rival Mitsubishi Tanabe is paying...

      

Related Stories

 

Original Article: Deal Watch: Takeda Continues Transaction Spree With Four More Deals

NEXT ARTICLE

More From BioPortfolio on "Deal Watch: Takeda Continues Transaction Spree With Four More Deals"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...